Literature DB >> 16204055

Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.

Sujna Raval-Fernandes1, Valerie A Kickhoefer, Christina Kitchen, Leonard H Rome.   

Abstract

Vault poly(ADP-ribose) polymerase (VPARP) and telomerase-associated protein 1 (TEP1) are components of the vault ribonucleoprotein complex. Vaults have been implicated in multidrug resistance of human tumors and are thought to be involved in macromolecular assembly and/or transport. Previous studies showed that VPARP-deficient mice were viable, fertile, and did not display any vault-related or telomerase-related phenotype, whereas disruption of telomerase-associated protein 1 in mice led to reduced stability of the vault RNA and affected its stable association with vaults, although there were no telomerase-related changes. In this study, we evaluated the susceptibility of Vparp-/- and Tep1-/- mice to dimethylhydrazine-induced colon tumorigenesis and urethane-induced lung tumorigenesis. Mice received i.p. injections of either 1 g/kg body weight of urethane twice a week for 2 weeks or 20 mg/kg body weight of dimethylhydrazine once a week for 10 weeks and were analyzed after 10 and 60 weeks, respectively. The colon tumor incidence and multiplicity were significantly higher and colon tumor latency was significantly shorter in Vparp-/- mice compared with wild-type mice. Increased colon tumor incidence, multiplicity, and reduced tumor latency were also seen in Tep1-/- mice, however, these results were statistically not significant. Lung tumor multiplicities were increased in both Vparp-/- and Tep1-/- mice but were not significant. The increase in carcinogen-induced tumors in VPARP-deficient mice is the only phenotype observed to date, and suggests a possible role for VPARP, directly or indirectly, in chemically induced neoplasia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204055     DOI: 10.1158/0008-5472.CAN-05-0770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  ADP-ribosyltransferases and poly ADP-ribosylation.

Authors:  Chao Liu; Xiaochun Yu
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

Review 2.  PARP inhibitor treatment in ovarian and breast cancer.

Authors:  Marcie K Weil; Alice P Chen
Journal:  Curr Probl Cancer       Date:  2011 Jan-Feb       Impact factor: 3.187

Review 3.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

4.  Poly(ADP-ribose) glycohydrolase silencing down-regulates TCTP and Cofilin-1 associated with metastasis in benzo(a)pyrene carcinogenesis.

Authors:  Haiyan Huang; Xuan Li; Gonghua Hu; Xiyi Li; Zhixiong Zhuang; Jianjun Liu; Desheng Wu; Linqing Yang; Xinyun Xu; Xinfeng Huang; Jianqing Zhang; Wen-Xu Hong; Jianhui Yuan; Wei Gao; Yinpin Liu
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 5.  Trial watch - inhibiting PARP enzymes for anticancer therapy.

Authors:  Antonella Sistigu; Gwenola Manic; Florine Obrist; Ilio Vitale
Journal:  Mol Cell Oncol       Date:  2015-06-10

6.  Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes.

Authors:  Matteo Citarelli; Sachin Teotia; Rebecca S Lamb
Journal:  BMC Evol Biol       Date:  2010-10-13       Impact factor: 3.260

7.  Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer.

Authors:  Chuan-Ling Wang; Yi Tang; Ming Li; Ming Xiao; Qing-Shu Li; Lian Yang; Xian Li; Ling Yin; Ya-Lan Wang
Journal:  Cancer Manag Res       Date:  2021-03-12       Impact factor: 3.989

8.  PARP16/ARTD15 is a novel endoplasmic-reticulum-associated mono-ADP-ribosyltransferase that interacts with, and modifies karyopherin-ß1.

Authors:  Simone Di Paola; Massimo Micaroni; Giuseppe Di Tullio; Roberto Buccione; Maria Di Girolamo
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

9.  MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy.

Authors:  Luis Alberto Henríquez-Hernández; Mercedes Moreno; Agustín Rey; Marta Lloret; Pedro C Lara
Journal:  Radiat Oncol       Date:  2012-08-29       Impact factor: 3.481

10.  Recruitment of the major vault protein by InlK: a Listeria monocytogenes strategy to avoid autophagy.

Authors:  Laurent Dortet; Serge Mostowy; Ascel Samba-Louaka; Ascel Samba Louaka; Edith Gouin; Marie-Anne Nahori; Erik A C Wiemer; Olivier Dussurget; Pascale Cossart
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.